| 12. Brain circuitry that is thought to be involved in obesity is also implicated in S Gill, AM Sharma, DW Birch, S Karmali, GJ Wang Psychiatric Annals 41 (10), 2011 | | 2011 |
| 1528P Phase I trial of the first-in-class agent CEND-1 in combination with gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer A Dean, S Gill, M McGregor, V Broadbridge, HA Jarvelainen, TJ Price Annals of Oncology 31, S941, 2020 | 9 | 2020 |
| 1606P Impact of COVID-19 (SARS-CoV-2, C19) on medical oncologists (MOs) and cancer care: A Canadian Association of Medical Oncologists (CAMO) survey study S Gill, B Colwell, S Welch, D Hao Annals of Oncology 32, S1148, 2021 | | 2021 |
| 171 Sorafenib for Advanced Hepatocellular Carcinoma A Shingina, ALM Hashim, M Haque, MW Suen, EM Yoshida, S Gill, ... Gastroenterology 5 (142), S-42, 2012 | 2 | 2012 |
| 203 Current and Future Approaches to Target the Epidermal Growth Factor Receptor and Its Downstream Signaling in Metastatic Colorectal Cancer Michael S. Lee, Scott Kopetz 219 … A Soni, E Chu, C Molinari, F Matteucci, P Caroli, A Passardi, M Davidson, ... | | |
| 24P Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts D Basile, J Seligmann, GA Martinez, T André, C Gallois, RM Goldberg, ... Annals of Oncology 35, S12-S13, 2024 | | 2024 |
| 505P The impact of COVID-19 on the wellness and resilience of the Canadian medical oncology workforce: A Canadian Association of Medical Oncologists survey L Jones, B Colwell, D Hao, S Welch, A Campbell, S Gill Annals of Oncology 33, S774, 2022 | | 2022 |
| 634P The ave-rec phase II trial of PD-L1/PD-1 blockade with avelumab plus chemoradiotherapy for resectable ESMO high risk rectal cancers M Michael, R Wong, S Gill, A Strickland, N Pavlakis, J Shapiro, E Link, ... Annals of Oncology 34, S450, 2023 | | 2023 |
| 71 Treatment of Advanced BRAF-Mutated Colorectal Cancer: Where We Are and Where We Are Going Chen Sun, Sofia España, Cristina Buges, Laura Layoffs, Cinta Hierro, Jose Luis … PM Horsthuis, RGH Beets-Tan, PJ Tanis, CAM Marijnen, M Kusters, ... | | |
| A decade of sheep genetics: what have we achieved C Collison, D Brown, S Gill, H Chandler, R Apps, A Swan, R Banks Proceedings of the World Congress on Genetics Applied to Livestock …, 2018 | 4 | 2018 |
| A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation TLEPI Study Ophthalmology 105 (9), 1780-1786, 1998 | 33 | 1998 |
| A hypothesis-generating study using electrophysiology to examine cognitive function in Colon Cancer patients SH Hung, S Mutti Jaswal, SE Neil-Sztramko, JWY Kam, N Niksirat, ... Archives of Clinical Neuropsychology 35 (2), 226-232, 2020 | 3 | 2020 |
| A morbidity survey for chronic illness by the household interview technique JS Gill Indian Journal of Public Health 26 (1), 53-57, 1982 | 3 | 1982 |
| A network meta-analysis (NMA) of randomized controlled trials (RCT) of chemotherapy regimens for metastatic pancreatic cancer (mPC). G Gresham, S Gill, GA Wells, DJ Jonker Journal of Clinical Oncology 31 (15_suppl), 4050-4050, 2013 | 2 | 2013 |
| A new system for collecting and processing phenotypic and genetic information from sheep for improved selection tools. KG Geenty, JHJ van der Werf, KP Gore, AJ Ball, S Gill Proceedings of the Association for Advancement in Animal Breeding and …, 2009 | 4 | 2009 |
| A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen AM Scott, N Tebbutt, FT Lee, T Cavicchiolo, Z Liu, S Gill, AMT Poon, ... Clinical cancer research 13 (11), 3286-3292, 2007 | 77 | 2007 |
| A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors AM Scott, FT Lee, N Tebbutt, R Herbertson, SS Gill, Z Liu, E Skrinos, ... Proceedings of the National Academy of Sciences 104 (10), 4071-4076, 2007 | 306 | 2007 |
| A Phase I single dose escalation trial of ch806 in patients with advanced tumors expressing the 806 antigen AM Scott, SS Gill, F Lee, Z Liu, E Skrinos, C Murone, T Saunder, ... Journal of Clinical Oncology 24 (18_suppl), 13028-13028, 2006 | 12 | 2006 |
| A phase I–II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI# 5798) JJ Knox, XE Chen, R Feld, M Nematollahi, R Cheiken, G Pond, ... Investigational New Drugs 26, 193-194, 2008 | 15 | 2008 |
| A phase I/II study of the Src inhibitor saracatinib (AZD0530) in combination with gemcitabine in advanced pancreatic cancer DJ Renouf, MJ Moore, D Hedley, S Gill, D Jonker, E Chen, D Walde, ... Investigational new drugs 30, 779-786, 2012 | 64 | 2012 |
